NCT00411580View on ClinicalTrials.gov

Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Alzheimer's Disease
Interventions
BIOLOGICAL

CAD106

DRUG

Placebo

Trial Locations (3)

204 02

Novartis Investigative Site, Malmo

141 86

Novartis Investigative Site, Stockholm

Unknown

Novartis Investigative Site, Stockholm

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY